The Emory Dermatology Department provides a complete range of basic services for disorders of the skin, hair, and nails, as wells as aesthetic treatments targeted to improve the appearance of skin.
There are nine divisions that provide speciality services, including seven clinical divisions offering direct or referral services to patients. The divisions of Dermatopathology, Immunodermatology, and Clinical Pharmacology and Outcomes Research are support services for physicians throughout the community. A summary of services for each division is also listed below.
General and Consultive Dermatology
All our providers treat most basic skin disorders including mild eczema and psoriasis, acne, and warts. In addition, we routinely evaluate patients for skin cancer, do skin biopsies and other minor skin surgeries, including the removal of moles, skin tags, cysts, and uncomplicated skin cancers.
The Department of Dermatology has three Board Certified Pediatric Dermatologists and provides the most extensive scope of pediatric dermatology services in the state of Georgia. Drs. Mary Spraker, Leslie Lawley, Zakiya Rice, and Monique Gupta Kumar have unique training and experience in the diagnosis and management of childhood skin disorders including congenital and genetic skin diseases, vascular anomalies, inflammatory skin diseases, infectious diseases, and skin diseases associated with systemic diseases.
MOHS' Micrographic and Dermatologic Surgery
MOHS' Micrographic Surgery is a technique developed by Dr. Frederick Mohs in the 1940s as a precise method of treating certain skin cancers. It combines surgical removal of the cancer with immediate microscopic examination of the removed tissue to ensure that the tumor is completely removed. All margins are carefully examined, thus limiting the incidence of reoccurrence.
Cutaneous Lymphoma Clinic
A cutaneous lymphoma is a cancer of lymphocytes, a specific type of white blood cells that are present in the skin. Emory dermatologists work with a multidisciplinary team of oncologists and physicians for diagnosis and treatment. This multidisciplinary team coordinates physicians from Dermatology, Dermatopathology, Hematopathology, Hematology Oncology, Radiology, and Radiation Oncology to provide state of the art diagnostic and therapeutic approaches to the difficult to diagnose and treat disorder. No other medical center in the state of Georgia has developed this multidisciplinary approach.
Contact allergy, similar to what is frequently experienced by exposure to poison ivy, can be induced by a wide variety of substances at home and in the work environment. This disorder may be difficult to diagnose and can present with difficult to treat dermatitis which may persist for months to years. Emory Dermatology maintains a large library of allergens which can be used to define contact allergy. Dr. Robert Swerlick has over 20 years of experience in evaluating contact allergy.
Inflammatory Skin Disease Management
Inflammatory skin disease may develop as a consequence of the local skin environment or as a consequence of diseases that affect the skin and other organs. Emory Dermatology has one of the largest groups of physicians in the world with special training and board certification in Immunodermatology. Our expertise in the arena, both in terms of availability of specific diagnostic tools and experience and expertise in the use of immune modulating therapies is unique in the state of Georgia and is on par with the best Dermatology programs in the country.
Melanoma and Pigmented Lesion Center
Emory Dermatology participates in a multidisciplinary melanoma management group which incorporates elements of early detection, world recognized Dermatopathology, state of the art staging, clinical trials for advance disease, and basic research delving into the basic mechanisms of the disease. Early detection tools include our pigmented lesion clinics staffed by Drs. Chen and Washington, and access to "mole mapping" photographic services which provides critical information required for optimal surveillance. Drs. Chen and Arbiser are involved in fundamental studies into the impact and cause of melanoma moving the frontiers of our understanding. Appropriate patients for referral include:
- Those who have been diagnosed with a melanoma
- Those who have dysplastic nevus syndrome (many abnormal moles and a family or personal history of melanoma, which places them at greater risk for developing melanoma)
- Those referred by their primary physician for consultation on a particular lesion
NewsView all News
Emory Healthcare news from the Emory News Center
Photos: Emory Denim Day
April 25, 2017
New study uses freezing technique to target vagus nerve and obesity
April 24, 2017
Father, son share special bond; both receive cochlear implants
April 21, 2017
Photos: Ebola care team attends 'Facing Darkness' screening
April 20, 2017
Ready, set, go! for Heel to Heal Superhero 5K and Fundraiser
April 18, 2017
SIBR program shows teamwork in healthcare
April 17, 2017
Expert Q&A: The antibiotic resistance threat
April 12, 2017
Christy M. Norman joins Emory Healthcare as vice president of pharmacy services
April 07, 2017
Medical faculty recognized by their Emory peers on Doctors' Day
April 05, 2017
CMS report: eICU program reduced hospital stays, saved millions, eased provider shortage
April 05, 2017